Affiliation:
1. Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston 77225.
Abstract
Ceftibuten is a new orally active cephalosporin with significant bioavailability. Its in vitro activity was compared with those of other agents against 383 strains of enteric pathogens derived from clinical specimens. Ceftibuten was very active against the strains of the family Enterobacteriaceae tested (overall MIC for 90% of strains tested, 0.25 microgram/ml) but was less active against Campylobacter jejuni (MIC for 90% of strains, 16 micrograms/ml). The MBC was one to two dilutions higher than the corresponding MICs for most pathogens tested.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference26 articles.
1. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents;Andreasen J. J.;Acta Pathol. Microbiol. Immunol. Scand. Sect. B,1987
2. Bacteriological comparison of the activities of ceftriaxone, a new long acting cephalosporin, with those of other new cephalosporins;Arisawa M.;Chem. Pharm. Bull.,1982
3. Sulfamethoxazoletrimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults;Barada F. A.;Antimicrob. Agents Chemother.,1980
4. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens;Carlson J. R.;Antimicrob. Agents Chemother.,1983
5. Antibiotic resistance of Salmonella in Europe and the United;Cherubin C. E.;States. Rev. Infect. Dis.,1981
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献